CNS
Overvalued by 57.9% based on the discounted cash flow analysis.
Market cap | $4.00 Billion |
---|---|
Enterprise Value | $3.96 Billion |
Dividend Yield | $2.39 (3.04613815957176%) |
Earnings per Share | $3 |
Beta | 1.44 |
Outstanding Shares | 51,058,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 25.51 |
---|---|
PEG | 108.91 |
Price to Sales | 8.88 |
Price to Book Ratio | 7.27 |
Enterprise Value to Revenue | 7.78 |
Enterprise Value to EBIT | 20.46 |
Enterprise Value to Net Income | 29 |
Total Debt to Enterprise | 0.04 |
Debt to Equity | 0.28 |
No data
No data